Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was in line with analysts’ consensus ...

I am updating my analysis on Elevance Health (NYSE:ELV) in light of Q4 and full-year 2024 earnings which were released pre-market on Thursday, January 23rd. I had previously rated Elevance Health ...

U.S. health benefits company Elevance Health, Inc. ELV shares have declined 29.6% quarter to date, underperforming its industry and the S&P 500 Index. Closing at $366.48 on Thursday, near its 52 ...

Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. Later ...

Hotchkis & Wiley Large Cap Fundamental Value Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: "Elevance Health, Inc. (NYSE:ELV) is a large ...

A noted rise in vaccinations for respiratory syncytial virus also aligns with UnitedHealth Group's Q4 report. Elevance Health beat the Street on both earnings and revenue for the fourth quarter of ...

Let’s take a look at how Elevance Health (NYSE:ELV) and the rest of the health insurance providers stocks fared in Q4. Upfront premiums collected by health insurers lead to reliable revenue ...

Elevance Health executives told investors on Thursday morning that they're confident in their 7% to 9% growth targets in Medicare Advantage based on early data coming out of the annual enrollment ...

Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7 ...

Elevance Health Inc. beats earnings expectations. Reported EPS is $5.62, expectations were $5.55. ELV isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter ...